Increasing Medication Access for Seniors Act of 2025
- Bill Number
- H.R. 6401
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-12-03: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-12-05T15:18:48Z
AI-Generated Summary
Purpose
The Increasing Medication Access for Seniors Act of 2025 aims to improve oversight of a Medicare Part D option that allows enrollees to pay their share of prescription drug costs (known as cost-sharing, like copays or deductibles) in fixed monthly amounts rather than per drug purchase. By requiring regular reports from the Department of Health and Human Services (HHS), the bill seeks to track usage, identify barriers, and promote awareness to help seniors manage drug expenses more predictably.
Key Provisions
- Reporting Schedule: HHS must submit reports to Congress starting 3 months after the bill's enactment, every 3 months for the first year, and annually thereafter until March 31, 2031.
- Report Content: Each report covers the prior 12-month period and includes:
- Number of Medicare Part D enrollees who elected the monthly capped payment option, broken down by U.S. Census regions, and separated by those in standalone prescription drug plans versus Medicare Advantage plans with drug coverage (MA-PD plans).
- An estimate of enrollees who did not elect the option but likely would benefit, based on their out-of-pocket drug costs (as determined by HHS).
- Details on HHS efforts to enable elections at the pharmacy point-of-sale (when buying drugs), including plans to make this available to all enrollees.
- Descriptions of facilitation methods, such as the Medicare.gov website, the annual Medicare & You handbook, the 1-800-MEDICARE hotline, and resources for healthcare providers.
- Other outreach activities targeting groups like healthcare provider associations, patient advocacy organizations, pharmacy benefit managers (companies that manage drug benefits), pharmacies, and health insurers.
- Definitions: Clarifies terms like "Medicare Part D enrollee" (individuals in drug plans under Medicare Part D), "covered Part D drug" (prescription drugs covered by these plans), "prescription drug plan" (standalone drug coverage), and "MA-PD plan" (Medicare Advantage plans including drug coverage).
Significant Changes to Existing Law
This bill does not alter the underlying Medicare Part D rules, which already include the monthly capped cost-sharing option (established under section 1860D-2(b)(2)(E)(i) of the Social Security Act). Instead, it introduces mandatory reporting requirements to monitor implementation and usage of this existing provision, ensuring greater transparency and potential refinements without creating new entitlements or funding.
Potential Impacts
- On Government Agencies: HHS will face increased administrative workload for data collection, analysis, and reporting, potentially leading to better-informed policy adjustments in Medicare drug programs.
- On Citizens: Medicare beneficiaries, especially seniors with high drug costs, may gain easier access to the capped payment option through improved outreach and point-of-sale tools, reducing financial unpredictability from large one-time copays. It could benefit low- and middle-income enrollees who struggle with fluctuating expenses.
- On International Relations: No direct impacts, as the bill focuses solely on domestic U.S. healthcare policy.
Main Stakeholders Affected
- Medicare Part D Enrollees: Primarily seniors and disabled individuals relying on prescription drug coverage, who could see more affordable and predictable cost-sharing.
- HHS and Congress: HHS handles reporting; Congress uses data for oversight and potential future legislation.
- Healthcare and Pharmacy Entities: Providers, pharmacies, pharmacy benefit managers, and insurers must support outreach and election processes, possibly integrating new tools at the point of sale.
- Advocacy Groups: Patient and consumer organizations representing Medicare users, who may amplify outreach efforts.
Notable Legal, Constitutional, or Political Implications
- Legal: Reinforces congressional oversight of executive agencies under the Administrative Procedure Act by mandating periodic reports, without raising separation-of-powers issues as it builds on existing statutory authority.
- Constitutional: Aligns with Congress's enumerated power to regulate interstate commerce and provide for public welfare (e.g., via Social Security programs), with no apparent free speech or due process concerns.
- Political: Bipartisan introduction (by a Republican and Democrat) suggests broad support for enhancing Medicare affordability; the reporting could inform debates on drug pricing reforms, potentially influencing future budgets or entitlement expansions without immediate fiscal mandates.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Kiggans, Jennifer A. [R-VA-2]
Cosponsors (1)
Rep. Krishnamoorthi, Raja [D-IL-8]
Recent Actions
- 2025-12-03: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-12-03: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-12-03: Introduced in House
- 2025-12-03: Introduced in House
Bill Versions
- Increasing Medication Access for Seniors Act of 2025 — issued 2025-12-03 — PDF (4 pages)